Literature DB >> 2823160

Suppression of pulsatile LH secretion, pituitary GnRH receptor content and pituitary responsiveness to GnRH by hyperprolactinemia in the male rat.

S R Fox1, M T Hoefer, A Bartke, M S Smith.   

Abstract

To assess whether gonadotropin-releasing hormone (GnRH) release from the hypothalamus might be altered by hyperprolactinemia in the male rat, we measured in chronically hyperprolactinemic rats the pituitary GnRH receptor content and described the pattern of luteinizing hormone (LH) release during the postcastration rise in gonadotropin secretion 24 and 72 h after gonadectomy. In intact rats, the effect of hyperprolactinemia was determined by describing the pattern of LH secretion, pituitary GnRH receptor content and assessment of pituitary responsiveness to small doses of GnRH (1.0 ng). In addition, to determine the role endogenous opioids might play in inhibiting GnRH release in hyperprolactinemic rats, we examined the effect of both a continuous infusion and a bolus injection of the opioid antagonist naloxone on the pattern of LH release. Chronic hyperprolactinemia was achieved by implanting 4 pituitaries under the kidney capsules 3-4 weeks before study. Acute hyperprolactinemia was achieved by injecting rats with 1 mg ovine prolactin every 12 h for 3 days. Control animals were untreated or were chronically hyperprolactinemic rats in which the hyperprolactinemia was transiently reversed by treatment for 3 days with the dopamine agonist 2-alpha-bromoergocryptine. The mean LH concentration was greatly decreased at 24 postcastration in chronically hyperprolactinemic rats relative to controls. This decrease was associated with a decrease in LH pulse height and pulse amplitude and pituitary GnRH receptor content, but not with an increase in the LH interpulse interval. In contrast, the decrease in mean LH concentrations in hyperprolactinemic animals at 72 h postcastration was primarily associated with a significantly longer LH interpulse interval than that observed in control animals. Chronic hyperprolactinemia in intact rats decreased the pituitary GnRH receptor content, in addition to decreasing the mean LH concentrations during pulsatile GnRH administration. Chronic hyperprolactinemia also inhibited LH release relative to controls during the continuous 4-hour infusion of naloxone and in response to a bolus injection of naloxone. However, in acutely hyperprolactinemic intact male rats a bolus injection of naloxone increase LH secretion 20 min later to levels similar to those obtained in control rats. In summary, these results indicate that chronic hyperprolactinemia decreased LH secretion by primarily decreasing GnRH secretion as suggested by a decrease in pituitary GnRH receptor content and a decrease in LH pulse frequency and pulse amplitude.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823160     DOI: 10.1159/000124844

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  5 in total

Review 1.  60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-prolactin axis.

Authors:  David R Grattan
Journal:  J Endocrinol       Date:  2015-06-22       Impact factor: 4.286

2.  The Influence of Anandamide on the Anterior Pituitary Hormone Secretion in Ewes-Ex Vivo Study.

Authors:  Dorota Tomaszewska-Zaremba; Karolina Wojtulewicz; Kamila Paczesna; Monika Tomczyk; Katarzyna Biernacka; Joanna Bochenek; Andrzej Przemysław Herman
Journal:  Animals (Basel)       Date:  2020-04-17       Impact factor: 2.752

Review 3.  Lactational Amenorrhea: Neuroendocrine Pathways Controlling Fertility and Bone Turnover.

Authors:  Anna Calik-Ksepka; Monika Stradczuk; Karolina Czarnecka; Monika Grymowicz; Roman Smolarczyk
Journal:  Int J Mol Sci       Date:  2022-01-31       Impact factor: 5.923

Review 4.  Hypogonadism in Male Patients with Pituitary Adenoma and Its Related Mechanism: A Review of Literature.

Authors:  Zisheng Yan; Ting Lei
Journal:  Brain Sci       Date:  2022-06-17

5.  Kisspeptin Overcomes GnRH Neuronal Suppression Secondary to Hyperprolactinemia in Humans.

Authors:  Katerina Hoskova; Nora Kayton Bryant; Margaret E Chen; Lisa B Nachtigall; Margaret F Lippincott; Ravikumar Balasubramanian; Stephanie B Seminara
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.